Navigation Links
World's Top 20 Pharmaceutical Companies Deploy Revolutionary H-Cube(R) From ThalesNano Inc.

BUDAPEST, Hungary and LONDON and PRINCETON, New Jersey, July 16 /PRNewswire/ -- ThalesNano Inc. today announced, that within three years from the original introduction of its H-Cube product, 20 out of the top 20 pharmaceutical companies have introduced and adopted the technology.

The H-Cube(R) Continuous-flow Hydrogenation Reactor is a bench-top standalone hydrogenation reactor, uniquely combining continuous-flow chemistry with endogenous on-demand hydrogen generation and a disposable catalyst cartridge system. It allows safe, fast and cost-efficient hydrogenation with superior yield when compared to conventional methods. The H-Cube and the other novel Cube series flow reactor systems developed by ThalesNano Inc. are showing tremendous benefits in the drug discovery process including shorted development time, increased cost efficiency and reduced environmental impact.

"Having all of the top 20 pharmaceutical companies as H-Cube users is a real testimony that the instrument is changing the process of how drugs are developed and the benefits that can be derived as a result", said Dr. Laszlo Urge, CEO of ThalesNano Inc. "Our early customers are now using our technology at multiple sites on four continents. H-Cube has become their first line of technology for catalytic hydrogenations. After establishing our continuous process technology in the discovery labs of the life sciences industry we are moving into the early scale up and full production with the new versions of the systems."

Dr. Ferenc Darvas, President and chairman of ThalesNano Inc. said. "It is clear that our strategy of providing a disruptive technology to the industry is working. The benefits of these technologies over conventional batch chemistry include the rapid synthesis of organic compounds, in particular under until now unrealizable hazardous reaction conditions. Further benefits include "Green Chemistry" by minimizing waste, energy consumption and raw material use, lab automation, and rapid scale-up from mg to kg quantities, which reduces CAPEX and OPEX while speeding time to market."

For more information please go to:

About ThalesNano Inc.:

ThalesNano is a world-leading provider of continuous process chemistry instruments in the rapidly developing market of laboratory and process scale flow reactors. The company has the widest portfolio of bench-top continuous process instruments. Its R&D 100 award winning H-Cube(R) continuous-flow hydrogenation reactor and the pilot plant scale version H-Cube Midi(TM) are used in hundreds of laboratories in four continents and have become the new industry standard for hydrogenation.

Contact: Laszlo Urge, Ph.D., CEO, e-mail:, Telephone: +36-1-880-8500

SOURCE ThalesNano Nanotechnology Inc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
2. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
3. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
6. ViroPharma To Acquire Lev Pharmaceuticals
7. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
8. Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
9. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
10. Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.
11. Alexion Pharmaceuticals Invites You to Participate in its Second Quarter 2008 Results Conference Call and Web Cast
Post Your Comments:
(Date:11/24/2015)... 2015  Clintrax Global, Inc., a worldwide provider of clinical research ... announced that the company has set a new quarterly earnings record ... quarter growth posted for Q3 of 2014 to Q3 of 2015. ... Mexico , with the establishment of an Asia-Pacific ... United Kingdom and Mexico ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
(Date:11/24/2015)... ... 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions for production, ... to serve as Chief Operating Officer. , Having joined InSphero in November ... and was promoted to Head of InSphero Diagnostics in 2014. There she has ...
(Date:11/24/2015)... 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... company,s president and chief executive officer, will present at the ... in New York City . The presentation ... 1, 2015 at 9:30 a.m. EST. ... website at least 15 minutes prior to the presentation to ...
Breaking Biology Technology:
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
Breaking Biology News(10 mins):